Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The momentum is backed by broader data
Regulatory update (August 2026): PCAC voted 86 to recommend BPC-157 for the 503A Bulk Drug Substances List at the July 23, 2026 hearing, overriding FDA staffs own recommendation
Want 5 mg from a 20 mg/mL vial
Within this FM 2.0 lens, GLP-1 therapy becomes a catalyst, not a crutch
Known gastroparesis or severe functional dyspepsia History of pancreatitis (particularly unexplained) Active gallbladder disease or prior complications Severe IBS-C unresponsive to standard measures Significant reflux worsened by delayed emptying Planned procedures under sedation/general anesthesia (coordinate care) These arent automatic nos, but they do call for individualized riskbenefit discussions
US$ 24.38
US$ 28.28
US$ 25.82
